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Abstract 
BACKGROUND:  Recent studies have found that OSA without the use of CPAP is an 
independent risk factor for cardiovascular disease and hypertension, which can lead to 
myocardial infarction (MI) and cerebral vascular accident (CVA) or stroke.  This increases 
patient morbidity and mortality rates as well as medical costs.  In those suffering from a 
myocardial infarction (MI) or cardiovascular accident (CVA), an important intervention is proper 
screening for the presence of OSA while in the acute care setting. The STOP BANG screening 
instrument is a simple yet effective tool in assessing for sleep apnea symptoms with a respective 
sensitivity of 93% for detecting moderate OSA and 100% in detecting severe OSA.  
OBJECTIVE:  To educate participating nursing staff on using the STOP BANG screening 
instrument, and implementing it within the MI and CVA populations.  After completion of the 
implementation period, screening adherence was assessed as well as patient demographics.    
METHODS: A literature review was conducted and the STOP BANG screening instrument was 
selected to assess for OSA.  Participating nurses were educated on the use of the STOP BANG 
screening instrument who then implemented the tool on the MI and CVA populations. A pilot 
study was conducted that utilized a descriptive and qualitative study and involved a retrospective 
chart review that was one time only, and included a two-part study.  The setting was within the 
ICU and 5 East Cardiac Units of Norton Brownsboro Hospital (NBH) from September 28, 2017 
through December 17, 2017.  RESULTS:  The participation rate in the ICU was 78% and 100% 
in the 5 East Cardiac unit. Within the ICU a 60% screening adherence rate was achieved for 
CVA patients with a 40% non-adherence rate.  For MI patients a 38% adherence rate was 
achieved for the ICU and 5 East units combined, and a 62% non-adherence rate.   Among patient 
demographics, results were as follows:  positive screens requiring supplemental oxygen was 
(P=.214), positive screens vs negative screens and the use of BiPAP were (P=.074) and 
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(P=1.000), notes made in records for positive screens were 9 out of 18 or 50% adherence.  
CONCLUSIONS:  Nurse provider participation was high within the ICU and 5 East Cardiac 
units.  Screening adherence was higher among the CVA patient population compared to the MI 
population. There was no significance or correlations between the use of supplemental oxygen or 
the use of BiPAP, and positive STOP BANG screens.  There was statistical significance between 
male patients with higher BMI's and positive STOP BANG screens.  These results indicate that 
more research is required with larger sample sizes and multiple facilities to acquire more reliable 
results for generalizability.   
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Background 
Cardiovascular disease and hypertension are two factors in the development of myocardial 
infarction (MI) and cerebral vascular accident (CVA) or stroke.  Recent studies indicate that 
obstructive sleep apnea (OSA) without the use of continuous positive airway pressure (CPAP) is 
an independent risk factor for cardiovascular disease and hypertension (Martinez-Garcia et al. 
2013; Barbe et al. 2012; Chen et al. 2015).  Chen et al. (2015) concluded that in elderly patients, 
the risk of death in those without CPAP therapy was higher than those with it.  Obstructive sleep 
apnea has been identified through large epidemiological studies to be an independent risk factor 
for stroke (Barone & Krieger, 2013).  A study with more than 6000 patients demonstrated that 
those with OSA has a 3 and 4-fold increased odds ratio for ischemic heart disease and 
cerebrovascular disease compared to the control population (Barone & Krieger, 2013).   
 Cardiovascular disease and stroke are major causes of morbidity and mortality in the 
United States.  Cardiovascular disease is the leading cause of death for both men and women.  
Around 610,000 or 1 in 4 people die from it each year (Centers for Disease Control and 
Prevention [CDC], 2015).  The U.S. spends $108.9 billion dollars annually to cover lost 
production, medications and health care services from cardiovascular disease (CDC, 2015).  
Stroke is a major cause of disability in the U.S. and the fifth leading cause of death (CDC, 2016).  
Each year 1 person dies about every four minutes in the U.S. from a stroke which is about 
130,000 people or 1 in 20 deaths (CDC, 2016).  About 800,000 people suffer from a stroke each 
year and the U.S. spends $34 billion in health care costs including medications and missed days 
of work (CDC, 2016).    
This background information reveals that OSA is a risk factor for cardiovascular disease 
that can impact healthcare and costs.  There are no OSA screening tools within the Norton 
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Healthcare system other than the peri-operative area of Norton Brownsboro Hospital that only 
screens for OSA in surgical patients.  To implement a protocol such as the STOP BANG 
screening instrument, evidence must support the education as a means for implementing 
evidence-based practice.   The Iowa Evidence-based Practice Model is an example of how to 
bring evidence into practice and uses a 7-step process to introduce, develop and evaluate 
evidence-based practice (British Journal of Medicine, 2011).   The model promotes the quality of 
patient care, helps control healthcare costs, and can be used to implement practice change at the 
unit or organization level (Brown, 2014). This model could be useful in implementing a practice 
change such as the STOP BANG screening instrument within the Norton Healthcare 
organization.  
Screening Instruments 
A literature review was completed to choose an appropriate OSA screening instrument 
for the MI and CVA populations.  The databases Medline, PubMed, Ebscohost, and CINAHL 
were used to search for current evidence using the terms, obstructive sleep apnea screening, 
obstructive sleep apnea questionnaire, testing, MI, CVA, and cardiovascular health.  The results 
were limited to English, age 18+, and published within the last 10 years.   
A total of 6 studies were chosen that met the criteria.  The literature review provided 
evidence that the most reliable and accurate OSA screening tools were the STOP BANG 
questionnaire, Berlin questionnaire, and Epworth Sleepiness Scale. A tool needed to be selected 
which was not only reliable and accurate but easy to use in a timely manner by nursing staff.  
The Amra et al., (2018), recommended a sleep study with Polysomnography (PSG) as the gold 
standard diagnostic but compared the 3 questionnaires.  Their results indicated the sensitivities of 
the Berlin, STOP-BANG, and ESS were 86.42%, 81.46%, and 59%, respectively.  Specificities 
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of Berlin, STOP-BANG, and ESS were 52.94%, 82.35%, and 76.47%, respectively.  They 
concluded the Berlin and STOP-BANG were more sensitive and accurate than the Epworth 
Sleepiness Scale in screening for OSA.  A systematic review and meta-analysis of 9,206 patients 
by (Nagappa et al., 2015), examined the validation of the STOP BANG questionnaire as a 
screening tool for OSA.  The study revealed that the STOP-BANG questionnaire had a 94% and 
96% sensitivity in detecting moderate to severe and severe sleep apnea.  It was also stated the 
STOP-BANG is a practical, short, straight forward test that takes approximately 1-2 minutes, and 
has a 90-100% response rate.  Their conclusion was that the STOP-BANG has a high 
performance and the higher the score, the higher the probability of moderate to severe sleep 
apnea.  A study by Chung et al. (2016), associated with the American College of Chest 
Physicians, concluded that the STOP-BANG is a concise, effective, and reliable OSA screening 
tool with a sensitivity to detect moderate to severe OSA and severe OSA of 93% and 100%.  In 
comparing the 3 questionnaires, it concluded that the STOP BANG was a more accurate tool for 
detecting mild, moderate and severe sleep apnea (Chung et al. 2016).  For the Berlin, STOP-
BANG and Epworth, the pooled sensitivity levels for moderate sleep apnea were 77%, 90%, 
40%, and specificity levels were 44%, 36% and 62%.  For severe sleep apnea the sensitivity 
levels were 84%, 93% and 58%, and specificity levels were 38%, 35% and 60%.  No benchmark 
data from similar “best practice” institutions or programs could be found specifically for OSA 
screening pertaining to MI and CVA within the acute care setting.  However, a QI project 
conducted by the American Society of Peri-Anesthesia Nurses in 2011, revealed a safer patient 
perioperative environment was created by incorporating the STOPBANG screening tool.  The 
pilot project used the Iowa Model of evidence based practice and reviewed patient data pre- and 
post implementation of the OSA screening tool (Lakdawala, 2011).  According to Chung et al. 
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(2012), the STOP-BANG   is a simple yet effective tool in assessing for sleep apnea symptoms 
with a respective sensitivity of 93% for detecting moderate OSA and 100% in detecting severe 
OSA.  
  After reviewing the literature, the STOP-BANG tool is a valid and reliable instrument in 
screening for sleep apnea that is quick and simple to use.  STOPBANG is an acronym that stands 
for Sleepiness, Tiredness, Observed apnea, high blood Pressure (STOP), BMI, Age, Neck 
circumference, Gender (BANG).  Scores range from 0-8 where higher scores equal higher risks.  
Scores from 0-2 are classified as low risk for moderate to severe OSA, where scores of 5-8 are 
classified as high risk according to (Chung et al. 2013).   Scores between 3-4 require further 
criteria for classification.  An example would be a patient with a score > 2 but has a BMI of 35, 
would be classified as high risk for having moderate to severe OSA (Chung et al. 2013).  A study 
by Chung et al. (2012), evaluated the association between STOP BANG scores and the 
probability of OSA.  The study concluded that a score of 5-8 identified patients as having a high 
probability of having moderate to severe OSA.  It is important to note that the STOP BANG 
screening tool is only for assessing for symptoms of OSA and is not diagnostic indicator. 
Purpose 
The specific aims of this study were to implement the STOP BANG protocol within the 
Norton Brownsboro ICU and 5 East Cardiac units, evaluate adherence to the protocol by the 
health care providers to the protocol, and determine if there is an association between positive 
STOP BANG screens and the use of supplemental oxygen or BiPAP.  Implementation of the 
project involved education of at least 75% of the ICU and 5 East nurses on how to use the STOP 
BANG protocol, measurement of protocol adherence, and retrospective data collection from the 
electronic medical record from the MI (DRG 280-282) and CVA (061-068) patient population to 
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measure the association between positive STOP BANG screens and the use of supplemental 
oxygen or BiPAP.  The six following research questions guided this study. 
1.  Was 75% of the nurses within the ICU and 5 East Cardiac units educated on how to 
use the STOP BANG screening instrument? 
2. Was screening with the STOP BANG instrument adhered to within the units for the 
specified populations? 
3.  Why was there screening non-adherence during the implementation phase?  
4:  What proportion of patients who screened positive on the STOP BANG tool required 
oxygen supplementation or increased oxygen requirements at night?  
5. Between those whose screened negative vs positive on the STOP BANG tool, who 
required use of BIPAP during nighttime hours during the implementation phase?  
6.  Was a note made in EPIC that the patient was given an education handout explaining a 
positive screen on the STOP BANG screening tool?   
Methods 
This evidence-based quality improvement project utilized a descriptive design to evaluate 
implementation and adherence to the STOP BANG screening protocol.  Additionally, a 
retrospective chart review was done to determine adherence to the protocol and to collect data to 
identify association between STOP BANG screening assessments (positive or negative) and use 
of BiPAP and oxygen requirements.  The target facility was the Norton Brownsboro ICU and 5 
East cardiac unit. This study had two parts, part one of the study evaluated effectiveness of the 
implementation of the protocol by determining the percentage of the registered nurses who 
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received training on how to use the STOP BANG protocol.  The primary investigator provided 
training on using the STOP BANG protocol during shift starts.   The education was started on 
9/28/2017 and lasted for one week to cover all shifts and consisted of how to implement the 
STOP BANG protocol (see Appendix A).  The registered nurses were educated to screen any 
patient that was admitted with an MI or CVA with the STOP BANG protocol.  This involved 
screening the patient with the 8 questions on the STOP BANG screening instrument (see 
Appendix A) and adding the "yes" column to obtain a score.  A positive score was between 5-8 
and indicated the patient was at higher risk for having moderate to severe OSA.  In the event a 
patient screened positive, the registered nurse was to place a note in the patient's chart stating 
they received a positive screen and was given an education handout (see Appendix B) explaining 
what this score meant and they should follow up with their primary care provider post discharge.  
The education handout was not given to patients with negative screens, however, the RN was 
asked to explain to the patient the purpose of the screen.  If a patient was not screened, the 
registered nurse was to make a note in the chart explaining why the screening was not 
completed.  Once screening was completed, the registered nurse then scanned the hard copy of 
the STOP BANG screening instrument into the EMR.  A roster of the ICU and 5 East nurses was 
given to the primary investigator from the unit managers.  This was compared to those who 
attended the training sessions and checked for duplicates.  There was a desired goal of at least 
75% of the nurses to attend training.  The second part of the study included a retrospective 
review of the EMR on all patients admitted to the ICU with an MI (DRG 280-282) or CVA 
(DRG 061-068), and 5 East with an MI (DRG 280-282) during the protocol implementation 
period.  The purpose of the chart review is to have measurable data for the objectives and assess 
adherence to the STOP BANG protocol, the reason the protocol was not adhered to, what 
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proportion of those patients who screened positive required oxygen at night or higher oxygen 
requirements, and compare BiPAP requirements in patients who screened positive with those 
who screened negative on the STOP BANG protocol.  The retrospective chart review also 
assessed if the patient who screened positive on the protocol received education via a handout on 
what a positive STOP BANG screen means.   The demographic variables of age, race and gender 
were measured in all patients admitted to the ICU with an MI (DRG 280-282) or CVA (061-068) 
and 5 East with an MI (DRG 280-282):  Other patient characteristics, that were not part of the 
study objectives, were evaluated to see if patients had incidents such as: BMI, pacemaker 
present, admission diagnosis of MI (DRG 280-282) or CVA (061-068), intubation, tachycardia, 
bradycardia, and the presence of Atrial fibrillation or Aflutter. These variables were recorded 
into a data collection tool on an Excel spreadsheet (see Appendix C). 
Setting 
The Norton Brownsboro Hospital ICU and 5 East Cardiac units located in Louisville, 
KY. is the setting of this study.   The study focused on OSA, which is a risk factor for 
cardiovascular disease, and this setting was chosen due to Norton Brownsboro Hospital being a 
comprehensive stroke center that has achieved advanced certification from the Joint Commission 
and American Heart Association. There is a high rate of admittance of CVA patients to the ICU 
which focuses on neurosurgery but also admits STEMI patients.  The ICU has a total of 36 beds 
with 16 beds located on the third floor and 20 beds located on the fifth floor.  The 5 East Cardiac 
unit has 21 beds and admits NSTEMI patients.  The study time frame was from September 28, 
2017 thru December 17, 2017. 
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Sample 
     The STOP BANG protocol was implemented as a pilot study where the primary investigator 
educated on the need, protocol and instrument use as part of an OSA screening protocol in a 
population of patients.  The study was to evaluate the implementation of the STOP BANG 
protocol and education was provided to a mass of nurses.  The primary investigator then 
measured the effectiveness of the implementation process on adherence to the STOP BANG 
protocol.  Data was also analyzed to determine associations/correlations between STOP BANG 
screening results and use of oxygen and BiPAP in patients who screened positive compared with 
those who screened negative to better understand effectiveness of implementing an OSA 
screening protocol in a high-risk population.   
     The sample for this study consisted of two populations.  The primary population was the 
Norton Brownsboro ICU and 5 East staff nurses who participated in the education sessions 
during implementation of the STOP BANG screening instrument. Nurses were asked to 
participate in the study by the primary investigator.  Participation was strictly voluntary and each 
nurse that participated signed consents explaining the study.  Approximately 80 nurses from the 
ICU were invited to participate, and 5 nurses from the 5 East cardiac unit.  All staff nurses who 
declined to participate were excluded from the study which resulted in a primary population of 
63 nurses from the ICU and 5 nurses from 5 East with a total number of 68.  Agency nurses were 
excluded from the study. 
     The secondary population of interest were those who suffered an MI or CVA during the 
period from Sept 28 through Dec 17, 2017, and met the inclusion criteria.  The inclusion criteria 
included patients admitted to the ICU with a diagnosis of myocardial infarction including a 
STEMI or NSTEMI, or cerebral vascular accident including Ischemic or Hemorrhagic strokes.  
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On 5 East those admitted with a NSTEMI were included (please refer to table 1 for a 
comprehensive list of DRG diagnosis codes used for inclusion criteria during admission).  Other 
inclusion criteria were those 18 years of age or older, and patients that were competent or able to 
answer the questions on the STOP BANG screening instrument.  If the patient was intubated, 
awake and could follow commands, family or friends could answer the questions on the STOP 
BANG screening instrument for the patient.    Non-English-speaking patients were included in 
the criteria as translator phones were available on the units.  Exclusion criteria were those 
younger than 18 years of age, and non-verbal or non-mentation patients with a decreased 
Glasgow Coma Scale who was not able to follow commands or answer questions.  
Data Collection 
Approval from the Norton Healthcare Office of Research Administration (NHORA) and 
University of Kentucky Institutional Review Board (IRB) was obtained before any data was 
collected.  The names of staff nurses who participated in the study, and signed consents given to 
them by the primary investigator, were obtained through rosters provided by the unit managers to 
obtain the percentage of nurses that participated in the study.  The study only involves the 
implementation of the STOP BANG protocol in a population of practicing nurses using an 
education approach and evaluation of adherence. 
  To collect patient data, an official request for secured data was submitted to the Norton 
Healthcare Office of Research Administration to identify and obtain reviewable patient records 
using the DRG codes listed in Table 1.   Data from the EPIC EMR was gathered at the Office of 
Nursing Research (room 5202) in a private room with a computer that was used to access patient 
charts.  The medical record number (MRN) was used to access patient charts.  A total of 52 
records were returned that met the DRG criteria for MI's and 129 records that met the DRG 
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criteria for CVA's for a total of 181 records.  The primary investigator (PI) entered the 181 
records to assess if screening was implemented.  Of the 52 records for MI's, 18 patients had 
screening adherence.  From the 34 remaining records, 28 did not have screening adherence, and 
6 records did not meet the inclusion criteria.  Of the 129 records for CVA's, 44 patients had 
screening adherence.  From the 85 remaining records, 29 did not have screening adherence and 
56 records did not meet the criteria.  Patient demographic variables were obtained and included 
age, race, and gender.  Other patient characteristics, that were not part of the study objectives, 
were evaluated to see if patients had incidents such as: BMI, pacemaker present, admission 
diagnosis of MI (DRG 280-282) or CVA (061-068), intubation, tachycardia, bradycardia, and the 
presence of Atrial fibrillation or Aflutter.  The primary investigator was evaluating any 
association between these incidents and OSA. 
Data Analysis  
  Part one of the study evaluated effectiveness of the implementation of the protocol by 
determining the percentage of the registered nurses who received training on how to use the 
STOP BANG protocol. There was a desired goal of at least 75% of the nurses from the ICU and 
5 East Cardiac unit to attend training. Descriptive statistics were utilized to measure the 
percentage of nurses that attended training and participated in the study.  Part two used 
descriptive statistics for objective two, as a percentage to measure the protocol screening 
adherence, or the percentage of patient charts that were screened.  No data analysis was used to 
for objective 3 to display why there was screening non-adherence, there were no notes made in 
the charts by the nurses on why there was non-adherence.  For objectives 4 and 5 the Chi-Square 
test was used to examine any association/correlation between the use of supplemental oxygen 
and the use of BiPAP and positive STOP BANG screens. For objective 6, descriptive statistics 
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was used as a percentage of the number of charts that had notes placed in them stating an 
education handout was given to positive screened patients.  Other confounding variables that 
were not part of the 6 objectives, such as patient demographics and patient characteristics, were 
examined and analyzed that could potentially affect the degree of association with positive STOP 
BANG screens.  Patient demographics included age, race and gender.  Patient characteristics 
included BMI, pacemaker present, admission diagnosis of MI (DRG 280-282) or CVA (061-
068), intubation, tachycardia, bradycardia, and the presence of Atrial fibrillation or Aflutter. 
Within these demographics and characteristics, the Paired t-test was used to compare continuous 
variables, and the Chi-Square Test was used to analyze categorical variables.  In cases were the 
Chi-Square or Paired t-test could not be used, the Fisher's Exact Test or Levene's Equality for 
Variances was used.  For statistical analysis, the Statistical Package for the Social Sciences 
(SPSS) version 23; was utilized, and a level of P<.05 was used for statistical significance 
throughout.  
Results 
  For objective 1, among the ICU nurses, after being approached by the primary 
investigator, 63 out of 80 nurses or 78% participated voluntarily in the study.  These 
participating nurses signed an informed consent provided by the primary investigator explaining 
the study.  The participating nurses were then educated on how to use and implement the STOP 
BANG protocol.  Among the 5 East Cardiac unit nurses, all 5 nurses or 100% participated 
voluntarily, signed inform consent and were educated on how to use and implement the STOP 
BANG protocol.  Nurses that decided not participate in the study simply stated they did not feel 
comfortable participating or they did not want to add voluntary work to their required duties.           
For objective 2, a total of 119 combined CVA and MI records met the inclusion criteria for 
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screening.  From the 119 records 73 of these were CVA's and 46 were MI's.  A total of 62 
records had screening adherence.  Among the 73 stroke patient records that met the inclusion 
criteria, 44 had screening adherence, and 29 had non-adherence, which yielded a 60% adherence 
rate for the ICU.  From the ICU 3E unit, screening was non-adherent on 14 of the CVA records, 
and on 5W screening was non-adherent on 15 of the CVA records.  The 5 East Cardiac unit does 
not admit CVA patients.  Among the 46 MI patient records that met the inclusion criteria, 18 had 
screening adherence which yielded a 39% adherence rate for the ICU and 5 East Cardiac units 
combined.  From the 5 East unit, screening was non-adherent on 20 MI records, ICU 5W was 
non-adherent on 4 MI records and 3E was non-adherent on 4 MI records.  For the 29 CVA 
records and 28 MI records that were non-adherent in screening, no note was made in the patient's 
chart as to why the screening was not completed.  Among the 62 screened patients, for all units 
the number of days to be screened revealed an average of 1.93 days (SD=1.367, range= 0-6).    
 Among the 62 records with screening adherence, 18 records or 29% screened positive 
with a STOP BANG score between 5-8, which consisted of 11 CVA's or 18%, 6 NSTEMI's or 
9% and 1 STEMI or 2%.  For objective 4, analysis of chart data revealed that the proportion 
among the 18 patients who screened positive, 8 or 44% required supplemental oxygen.  Using 
the Chi-Square/Fisher's Exact Test, the result revealed a P value of .214, which showed no 
association or correlation between the use of supplemental oxygen and a positive STOP BANG 
screen.  For objective 5, in examining those who screened negative vs positive and required the 
use of BiPAP during nighttime hours the following results were revealed:   For positive screens, 
2 patients or 11 % required the use of BiPAP during nighttime hours, using the Fisher's Exact 
Test, this revealed a P value of .074, which showed no association or correlation statistically 
between positive screens with the use of BiPAP and positive STOP BANG screens, but did show 
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clinical significance.  For negative screens, 16 patients or 89% did not required BiPAP use 
during nighttime hours. Using the Fisher's Exact Test, this revealed a P value of 1.000, which 
showed no association or correlation statistically between negative screens with the use of 
BiPAP.   These results revealed no association or correlation between positive vs negative 
screens and the use of BiPAP during nighttime hours.  For objective 6, in examining the 
frequency of notes made in the charts for positive screens, out of 18 positive screens, 9 notes or 
50% were placed in the charts.  Out of those 9 notes, 6 notes were placed in the records of 
patients with CVA's, and 3 for MI's.  These results pertained to the 6 objectives research 
questions. 
 The confounding variables that were not implicitly in the objectives, such as patient 
demographics and patient characteristics were of interest and used to describe the secondary-  
population within the ICU and 5 East Cardiac units.  These variables could have a potential 
effect on the degree of association between positive screened patients and objectives 4 and 5.  
The results for the patient demographics were as follows:  For positive screens the mean age of 
all patients was 63.22 years (SD=9.662).  Using the Levene's Test of Equality for Variances this 
resulted in a P value of .928, which showed no association or correlation between age and a 
positive STOP BANG screen.  For positive screens and race, using the Fisher's Exact Test this 
resulted in a P value of .550, which showed no association or correlation between race and 
positive STOP BANG screens.  For positive screens among gender, there were 13 males and 5 
females, using the Chi-Square Test for comparison, the P value result was .025, which showed a 
higher association or correlation between a positive STOP BANG screen among male vs female. 
Among the confounding patient characteristic variables, the results were as follows:  The BMI of 
positive screened patients demonstrated a mean value of 32.06 (SD = 6.812), using the Levene's 
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Test for Equality of Variances, a P value result of .005 was revealed.  This demonstrated an 
association or correlation between a higher BMI and a positive STOP BANG screen.  Among 
arrhythmias, no association or correlations were found between arrhythmias or the presence of 
OSA.  Using the Chi-Square Test, the results were as follows: Tachycardia revealed a P value of 
.538, Bradycardia revealed a P value of .444, A-Fib revealed a P value of 1.000, and no A-Flutter 
was present among positive screens.  Among those patients with positive screens who had 
pacemakers the results revealed a P value of 1.000, which showed no association or correlation 
between pacemakers and the presence a positive STOP BANG screen. Finally, for positive 
screens that were intubated, the result revealed a P value of 1.000, which showed no association 
or correlation between intubation and a positive STOP BANG screen.  It is important to note that 
no proportion of the sample reported a pre-existing diagnosis of OSA, including the 18 positive 
screens. 
Discussion 
 
  Within the 6 objectives, the major findings of this study showed that the primary 
population of nurse providers had a 78% participation rate from the ICU and 100% participation 
rate from the 5 East Cardiac unit.  This finding is important because without participation there is 
no study.  No similar studies could be found specifically to OSA screening within the acute care 
setting, however a 2012 psychology research paper found that drops in participation caused 
drops in the confidence of research findings.  A 100% participation rate is perfect but not always 
possible.  The paper mentioned that in reviewing standard research texts, a number was not 
identified for a participation rate to exceed to be scientifically acceptable, although some 
researchers mentioned 60%, 80% or 90% as the target participation rate (Journal of 
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Psychotherapy and Psychosomatics, 2012).   The clinical relevance of this is important because a 
drop in the confidence of research could potentially effect evidence based practice within the 
clinical setting.  The findings for the STOP BANG screening adherence rate was 60% for the 
CVA population and 39% for the MI population. It is difficult to determine the reasons for 62% 
low adherence rates for MI's due to notes not being placed within charts that were not screened.  
Another factor that may have affected screening from the 5 East unit was work burden. The 
participating nurses from this unit were also assistant nurse managers that not only had patient 
teams, but were also required to fulfill administrative duties.  Findings from this study suggest 
that there are no associations or correlations between positive screens and the use of 
supplemental oxygen or BiPAP use.  Although, clinical significance was found between positive 
screens and the use of BiPAP which simply means there is practical importance, and is a 
subjective interpretation of the result by a provider. 
The major findings of the confounding demographic variables not implicitly stated in the 
objectives showed there is no association or correlation between positive screens and age or race.  
However, there was an association or correlation between positive screens with males and 
positive screens.  Among the confounding patient characteristic variables, there was an 
association or correlation between positive screens and BMI and positive screens.  This finding 
was important since these are known characteristics of patients already diagnosed with OSA 
(Chui et al. 2017).  No associations or correlations were found between the remaining 
confounding patient characteristic variables such as tachycardia, bradycardia, A-Fib, A-Flutter, 
the presence of a pacemaker, and intubated patients with a positive STOP BANG screen.   
  There is currently no required screening protocol at NBH with the STOP-BANG or any 
other tool for OSA.  Education and "buy-in" of nurses on evidence-based OSA screening process 
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are important factors in helping to identify OSA in patients with MI or CVA.   The medical 
consequences of not identifying undiagnosed OSA in these populations would not allow to the 
providers or patients options for treatment to potentially improve outcomes. 
Limitations 
       This study had limitations with small sample sizes, as well as only being implemented on 
2 units within 1 facility.  Poor adherence to the STOP BANG screening protocol and a short 
implementation period were other study limitations.  Poor adherence rates limits data collection 
and the validity of the study.  A longer duration period may have allowed larger sample sizes 
which could have yielded different results.  The convenience sample of the patient population 
was mostly white in those who were screened and there were no minorities in the positive 
screens.  Another limitation was self-reporting as this is not completely reliable, patients may 
sometimes not be aware that they snore or have other symptoms.  There were however times 
when family would report for a patient.   
Recommendations for Future Study 
Steps must be taken to further asses the burden of OSA on the MI and CVA populations 
as well as increase provider awareness and screening.  Within this study, there was limited 
evidence to reveal the burden of OSA on these populations.  It is important to study the burden 
on these populations as literature has shown OSA is an independent risk factor for cardiovascular 
disease.  A large scale multi-unit, multi-level, multi-facility comparison with a longer duration 
period must be conducted to gain larger sample sizes to better understand the burden on these 
populations for more reliable and generalizable results.  This could be accomplished by getting 
buy-in from stakeholders throughout the Norton system on the need for OSA screening by 
presenting evidence-based research showing the implications and costs of untreated OSA, and 
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how it could impact readmission rates.  This would improve provider awareness and aide in the 
implementation process of OSA screening through better stakeholder support.  In addition to 
expanding studies to other facilities, increasing the evaluation period would also be beneficial in 
identifying trends over time.  A long evaluation period would give the results stronger reliability 
and validity.  To improve non-adherence rates, post implementation surveys to the providers 
should be conducted to evaluate reasons for non-adherence.  Future research questions may ask 
why non-adherence is prevalent within the OSA screening process.  Other research questions 
may ask, what providers should conduct OSA screening within the acute care setting, how 
prevalent is OSA among races other than whites, and what is the burden of OSA on the heart 
failure population.  Other patient characteristics should be tracked such admission diagnosis, the 
use of oxygen or CPAP, and desaturation events during the night and socio-economic status.  It 
would also be important to measure the co-morbid burden in the sample between positive and 
negative screens for OSA risk and mortality. Further development of a treatment protocol for 
those who screened positive for being at increased risk for OSA is needed to ensure follow up. 
Conclusion 
There are currently no recommendations on screening for OSA in the acute care setting.  
According to an article by the U.S.  Preventive Task Force (2017), screening is not recommend 
for OSA in asymptomatic adults.  Within the same article, the American College of Physicians 
does recommend a sleep study for those with daytime sleepiness, and The American Academy of 
Sleep Medicine recommends that routine health maintenance evaluations include questions about 
OSA and evaluation for risk factors (U.S. Preventive Task Force, 2017).  In an article by Kapur 
et al. (2017), The American Academy of Sleep Medicine (AASM) reports that an estimated 30 
million people in the U.S. suffer from sleep apnea.  The AASM does not mention screening 
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questionnaires for sleep apnea but does recommend an attended polysomnography in an 
accredited sleep center or home sleep apnea testing should be performed for suspected 
obstructive sleep apnea, (Kapur et al., 2017).   
One of the aims of this study was to show the burden of OSA on the MI and CVA 
populations in the acute care settings, and evaluate the use of supplemental oxygen or the use of 
BiPAP and associations with positive STOP BANG screens, these were objectives 4 and 5.  No 
significance correlation was found between the use of supplemental oxygen or the use of BiPAP 
and positive screens.  Within the special interest variables, a significant correlation was found 
between males and positive screens vs females.  A significant correlation was also found 
between a higher BMI and positive screens.  Although no significant correlations were found 
within objectives 4 and 5, this does not mean that screening should not be performed on these 
populations as results could be more reliable and generalizable with larger sample sizes. 
  One problem is the lack of knowledge from providers on the negative health effects of 
OSA due to a lack of standardized screening guidelines.  It is unknown within this study how 
well the STOP BANG screening instrument identified OSA symptoms in patients with a known 
diagnosis of OSA.  From the positive screened patients, none were known to have a prior 
diagnosis of OSA.  Screening is important as studies have shown that proper treatment of OSA 
can have positive health effects.  In this study, no correlation was found between Atrial 
Fibrillation and the presence of OSA, but a recent article concluded that studies of patients with 
Atrial Fibrillation suggest that there is a significant correlation between treatment of OSA by 
continuous positive airway pressure and maintaining sinus rhythm after electrical cardioversion, 
and improve catheter ablation success rates (Lintz et al., 2018).    A study by Olga et al. (2014), 
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found results which found a significant correlation between CPAP therapy and a positive effect 
on the long‐term survival in patients with ischemic stroke.   
Without standardized guidelines for the screening of OSA within the acute care setting, a 
lack of awareness will continue to exist.  More research must be conduct and steps must be taken 
to bring knowledge and awareness of OSA and its burden on cardiovascular disease populations 
so that screening processes may be implemented.   In the next steps, it would be reasonable to 
educate all major stakeholders within the Norton Brownsboro Hospital on the impact of 
untreated OSA on cardiovascular health and associated costs.  By utilizing this information and 
using a framework model such as the Iowa Evidence-based Practice Model, it would be feasible 
to continue an evidence-based practice such as the STOP BANG screening instrument and 
continue risk screening for OSA at Norton Brownsboro and eventually throughout the Norton 
system.  This pilot study was successful with high nurse participation and adherence rates and 
could be improved by including future treatment plans developed for positive screened patients 
requiring supplemental oxygen to CPAP while hospitalized, and follow up appointments post 
discharge.  There are major opportunities for prevention focus with a treatment plan for those 
who screen positive.  The next steps for future screening would include follow-ups on those 
patients who scored between 5-8.  On patients who screen positive, information such as time 
intervals, when was oxygen added, did they require CPAP or go home with a CPAP, and did 
they have a follow up sleep study, would allow a fuller understanding of the patient's clinical 
course.  This must be accomplished before we can understand and look for linkages between 
screening positive on the STOP BANG OSA risk assessment and readmission rates.  This 
work/study could potentially have influence on reducing readmission rates and costs. 
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Table 1. Inclusion List of Myocardial Infarction DRG codes n=52 
Inclusion Criteria List of Myocardial DRG codes 
DRG Codes   Diagnosis Definition  
280  ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W MCC
281  ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W CC
282  ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE W/O CC/MCC 
 
Table 2. Inclusion List of Stroke DRG codes n=129 
DRG Codes   Diagnosis Definition  
061  Ischemic stroke, precerebral occlusion or transient ischemia with thrombolytic agent 
with mcc 
062  Ischemic stroke, precerebral occlusion or transient ischemia with thrombolytic agent 
with cc 
063  Ischemic stroke, precerebral occlusion or transient ischemia with thrombolytic agent 
without cc/mcc 
064  Intracranial hemorrhage or cerebral infarction with mcc
065  Intracranial hemorrhage or cerebral infarction with cc or tpa in 24 hours 
066  Intracranial hemorrhage or cerebral infarction without cc/mcc
067  Nonspecific cva and precerebral occlusion without infarction with mcc 
068  Nonspecific cva and precerebral occlusion without infarction without mcc 
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Table 3. Demographic Characteristics 
Characteristic  Mean (SD) or n (%) 
Age  63.44 (14.400) 
BMI  28.87 (6.244) 
Gender 
   Male 
   Female 
 
31 (50%) 
31 (50%) 
Race 
    Blk 
    Cauc 
 
3 (4.8%) 
59 (95.2) 
Admitting Dx 
    CVA 
    NSTEMI 
    STEMI 
 
44 (71%) 
13 (21%) 
5 (8.1%) 
Screening Outcomes  Mean (SD or n (%) 
Pacemaker 
    Positive screens 
    Negative screens 
 
4 (6.5%) 
57 (91.9%) 
Tachycardia 
    Positive screens  
    Negative screens 
 
18 (29%) 
43 (69.4%) 
Bradycardia 
    Positive screens 
    Negative screens 
 
23 (37.1%) 
39 (62.9%) 
A fib 
    Positive screens 
    Negative screens 
 
2 (3.2%) 
59 (95.2%) 
Vent 
    Positive screens 
    Negative screens 
 
6 (9.7%) 
55 (88.7% 
Aflutter 
      Negative screens 
 
62 (100%) 
Desaturation during stay 
    Positive screens 
    Negative screens 
 
8 (12.9%) 
54 (87.1%) 
Negative screen with BiPAP 
    Positive 
    Negative 
 
2 (3.2%) 
60 (96.8%) 
Positive screen with BiPAP 
    Positive 
    Negative 
 
2 (3.2%) 
60 (96.8%) 
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Table 4. Comparison of characteristics 
  Screened positive (n=) 
 
Mean (SD) or n (%) 
Screened negative (n=) 
 
Mean (SD) 
P 
Age  63.22 (9.62)  63.52 (16.038)  .93 
BMI  32.06 (6.812)  27.28 (5.473)  .005 
Gender 
   Male 
   Female 
 
13 (72.2%) 
5 (27.8% 
 
18 (40.9%) 
26 (59.1%) 
 
.025 
Race 
   Caucasian 
   Black 
 
18 (100%) 
0 
 
41 (93.2%) 
3 (6.8%) 
.550 
Admitting Dx 
  CVA 
   NSTEMI 
   STEMI 
 
11 (61.1%) 
6 (33.3%) 
1 (5.6%) 
 
33 (75%) 
7 (15.9%) 
4 (9.1%) 
.302 
Pacemaker 
    
 
  1 (5.9%) OSA 
17 (94.1%) 
CVA 41 (93.2%) 
MI 3 (6.8%) 
1.000 
Tachycardia 
    
 
 6 (35.3%) OSA 
 11 ((%64.7)  
 
12 (27.3%) 
32 (72.7%) 
.538 
Bradycardia 
    
 
8 (44.4%) OSA 
10 (55.6) 
15 (34.1%) 
29 (5.9%) 
.444 
Intubated 
 
2 (11.8%) OSA 
16 (88.2%) 
4 (9.1%) 
40 (90.9%) 
1.000 
Aflutter 
    
0%  0%   
Desaturation  during 
stay 
    
 
4 (22.2%) OSA 
14 (77.8%) 
4 (9.1%) 
40 (90.9%) 
.214 
Negative BiPAP screen 
    
 
0 OSA 
18 (100%) 
2 (4.5%) 
42 (95.5%) 
1.000 
Positive BiPAP screen 
    
 
3 (11.8%) OSA 
15 (88.2%) 
0 (0%) 
44 (100%) 
.074 
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(Appendix B) Patient Education Handout 
STOP BANG Patient Education 
Handout 
Because of being in the ICU, a special test was done on you called the STOP 
BANG test to check for obstructive sleep apnea.  Your result indicates that you 
may be at risk for sleep apnea.  This tool is only used to assess your risk of having 
obstructive sleep apnea and not a diagnosis.  Having obstructive sleep apnea puts a 
person at higher risk for heart attack and stroke.  You are encouraged to follow up 
with your primary care physician after discharge and potentially setting up a sleep 
study workup. 
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(Appendix C) Audit Tool for patient data Post-Implementation 
Unique 
ID 
Age  Race  BMI  Admit 
dx 
Pacer
Y/N 
On 
vent
Tachy‐
cardia 
Brady
cardia
AFIB 
Aflutter
Screen 
completed 
1A                     
1B                     
1C                     
 
Unique 
ID 
Reason 
not  
Adhered 
to 
Positive 
screen  
O2 Range 
Desaturation 
During ICU 
stay 
Negative 
screen 
With BiPAP
Positive 
screen 
With 
BiPAP 
Education 
Handout 
Given 
Note 
Made in 
Chart 
1A               
1B               
 
 
